Trials / Unknown
UnknownNCT01588119
Register for New Oral Anticoagulants
Prospective Register Study to Record Safety and Efficacy of New Oral Anticoagulants
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- GWT-TUD GmbH · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients, who are adjusted to a new oral anticoagulant (Dabigatran, Rivaroxaban, Apixaban, Edoxaban) in routine treatment will recorded in this register. Within this register a characterization of patients (with regard to demography and indication) and therapy (with regard to medication, dose and duration) will be done. On basis of defined clinical relevant end points the long-term efficacy and safety will be evaluated.
Conditions
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2024-12-01
- Completion
- 2024-12-01
- First posted
- 2012-04-30
- Last updated
- 2023-01-18
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01588119. Inclusion in this directory is not an endorsement.